In a matter involving alleged abuse of the U.S. Pharmacopeia standard setting process, CRA examined market power for product dispensed through hospital and non-hospital sites of care. CRA’s expert found that in most uses, during the relevant time period there was ample evidence of competition, finding that the manufacturer at issue was effectively price constrained by existing competition.
Antitrust Economics for Lawyers 2026
Designed for antitrust practitioners without requiring an economics background, the book explains complex concepts in an accessible but rigorous way, pairing...